Resurge (retroperitoneal sarcoma surgery) 9th edition

Acquisizione competenze di sistema:Retroperitoneal sarcomas (rps) are rare cancers representing only 0.2% of cancers in adults with an average annual incidence of approximately 2.7 cases per million. these tumors originate in the retroperitoneum (“back of the abdomen”) and can reach massive size before detection. In fact, the median tumor size on presentation is approximately 20–30 cm. Overall, rps tend to cause local morbidity rather than metastasize. the mainstay of treatment for rps is surgical resection, and complete resection is the only chance for potential cure. the management of rps can be challenging and in individual cases, radiation and systemic therapy may be beneficial in both primary and recurrent disease.